Methylthioninium chloride Cosmo


methylthioninium chloride

This medicine is authorised for use in the European Union.


Methylthioninium chloride Cosmo is used in adults as a dye to help doctors see the lining of the colon (large bowel) more clearly and improve detection of lesions (abnormalities) during colonoscopy, a procedure to examine the colon through a tube with a camera.

Methylthioninium chloride Cosmo contains the active substance methylthioninium chloride.

Methylthioninium chloride Cosmo is a ‘hybrid medicine’. This means that it is similar to a ‘reference medicine’ containing the same active substance, but the authorised use, strength, pharmaceutical form and route of administration are different. The reference medicine for Methylthioninium chloride Cosmo is Metilénkék Pharmamagist, a medicine authorised in Hungary.

This EPAR was last updated on 26/08/2020

Authorisation details

Product details
Methylthioninium chloride Cosmo
Agency product number
Active substance
methylthioninium chloride
International non-proprietary name (INN) or common name
methylthioninium chloride
Therapeutic area (MeSH)
  • Colorectal Neoplasms
  • Colonoscopy
Anatomical therapeutic chemical (ATC) code
Publication details
Marketing-authorisation holder
Cosmo Technologies Ltd
Date of issue of marketing authorisation valid throughout the European Union
Contact address

Riverside II
Sir John Rogerson’s Quay
Dublin 2

Product information

19/08/2020 Methylthioninium chloride Cosmo - EMEA/H/C/002776 -


Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Other diagnostic agents

Therapeutic indication

Methylthioninium chloride Cosmo is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Assessment history

How useful was this page?

Add your rating